Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tyvaso for ARDS Prevention
NCT02370095Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2015
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
A Phase 2 trial of treprostinil in acute respiratory distress syndrome (ARDS), sponsored by University of North Carolina at Chapel Hill. Started Feb 2015; status: terminated.
02
Drugs
treprostinil
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02370095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02370095.